tiprankstipranks
Advertisement

IGRO - ETF AI Analysis

Compare

Top Page

IGRO

iShares International Dividend Growth ETF (IGRO)

Rating:62Neutral
Price Target:
IGRO’s rating reflects a generally solid, diversified portfolio of international dividend growers, led by strong contributors like Novartis and Toyota, which show robust financial health, positive earnings sentiment, and supportive valuations. Banks such as Royal Bank of Canada and Toronto Dominion Bank, along with healthcare names like Roche and Sanofi, also add stability but face some caution flags around overbought technical signals and valuation, while Iberdrola’s high debt and overbought signs slightly weigh on the fund. The main risk factor is the concentration in a few large financial, healthcare, and industrial names, where any downturn or correction in these areas could meaningfully impact the ETF.
Positive Factors
Low Expense Ratio
The fund charges relatively low fees, which helps investors keep more of their returns over time.
Broad International Diversification
Holdings spread across many countries, including Japan, the U.S., and several European markets, reduce reliance on any single economy.
Solid Recent Performance
The ETF has shown generally positive performance so far this year, supported by gains in several top holdings like Royal Bank of Canada, Novartis, Toronto-Dominion Bank, and Iberdrola.
Negative Factors
Concentration in Financials
A large portion of the portfolio is in financial companies, which can hurt returns if that sector faces stress.
Mixed Performance Among Top Holdings
Some major positions such as British American Tobacco, Nestlé, Roche, Sanofi, and Toyota have been weak this year, which can drag on overall results.
Limited Technology Exposure
The fund has only a small allocation to technology stocks, so investors may miss out if that sector continues to lead global markets.

IGRO vs. SPDR S&P 500 ETF (SPY)

IGRO Summary

IGRO is the iShares International Dividend Growth ETF, which follows the Morningstar Global ex-US Dividend Growth index. It invests in companies outside the U.S. that have a history of steadily increasing their dividend payments. Its holdings include well-known names like Nestlé, Novartis, Toyota, and Royal Bank of Canada, spread across many countries and sectors. Someone might invest in IGRO to diversify beyond the U.S. and seek a mix of income and long-term growth from stable global companies. A key risk is that international stocks can go up and down with global markets and currency swings.
How much will it cost me?The iShares International Dividend Growth ETF (IGRO) has an expense ratio of 0.15%, which means you’ll pay $1.50 per year for every $1,000 invested. This is lower than average for ETFs because it is passively managed, tracking an index of international dividend growth companies.
What would affect this ETF?The iShares International Dividend Growth ETF (IGRO) could benefit from global economic recovery and increased demand for dividend-paying stocks, especially in sectors like financials, healthcare, and utilities, which make up a significant portion of its holdings. However, potential risks include currency fluctuations, geopolitical tensions, and slower economic growth in international markets, which could negatively impact the performance of its top holdings and overall portfolio. Changes in interest rates or regulatory policies in key regions could also influence the ETF's future returns.

IGRO Top 10 Holdings

IGRO’s story is all about steady dividend growers outside the U.S., with a clear tilt toward financials and health care. Royal Bank of Canada and Toronto-Dominion are rising and doing much of the heavy lifting, giving the fund a solid Canadian banking backbone. On the defensive side, Nestlé is more or less steady, offering stability even as it has lost some steam this year. In health care, Novartis is quietly climbing while Roche and Sanofi are more mixed, keeping overall performance balanced across Europe and Canada with no single stock dominating the show.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Royal Bank Of Canada2.98%$36.81M$254.15B51.05%
75
Outperform
2.87%$35.37M
British American Tobacco2.85%$35.23M£92.32B36.11%
71
Outperform
Nestlé SA2.77%$34.21MCHF195.94B-5.61%
71
Outperform
Roche Holding AG2.60%$32.12M$323.93B32.62%
73
Outperform
Novartis AG2.59%$31.92MCHF206.95B24.69%
80
Outperform
Toronto Dominion Bank2.47%$30.46M$181.60B70.08%
74
Outperform
Sanofi2.15%$26.49M€88.01B-18.93%
75
Outperform
Iberdrola2.09%$25.77M€129.95B25.60%
67
Neutral
Toyota Motor2.08%$25.70M¥37.97T7.65%
80
Outperform

IGRO Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
85.58
Positive
100DMA
85.64
Positive
200DMA
82.24
Positive
Market Momentum
MACD
0.57
Positive
RSI
55.10
Neutral
STOCH
64.37
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IGRO, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 87.50, equal to the 50-day MA of 85.58, and equal to the 200-day MA of 82.24, indicating a bullish trend. The MACD of 0.57 indicates Positive momentum. The RSI at 55.10 is Neutral, neither overbought nor oversold. The STOCH value of 64.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IGRO.

IGRO Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$1.24B0.15%
62
Neutral
$8.74B0.07%
65
Neutral
$1.77B0.50%
62
Neutral
$1.76B0.54%
61
Neutral
$1.39B0.85%
61
Neutral
$1.17B0.65%
69
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IGRO
iShares International Dividend Growth ETF
87.94
14.53
19.79%
VIGI
Vanguard International Dividend Appreciation ETF
ILOW
AB International Low Volatility Equity ETF
CGIC
Capital Group International Core Equity ETF
WCMI
First Trust WCM International Equity ETF
IDVO
Amplify International Enhanced Dividend Income ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement